Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET3 | O43151 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | FBXL19 | Q6PCT2 | 4/20 | 0.47 |
| ▸ | CXXC5 | Q7LFL8 | 4/20 | 0.47 |
| ▸ | KDM2B | Q8NHM5 | 4/20 | 0.47 |
| ▸ | CXXC4 | Q9H2H0 | 4/20 | 0.47 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.47 |
| ▸ | TET1 | Q8NFU7 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TEAD3 | Q99594 | 2/20 | 0.40 |
| ▸ | TEAD1 | P28347 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 3/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20547259 | 1.00 | TET3 (0.47) | TET3KMT2AFBXL19CXXC5KDM2B | |
| SCHEMBL237862 | 1.00 | — | — | |
| SCHEMBL12764449 | 1.00 | TET3 (0.47) | TET3KMT2AFBXL19CXXC5KDM2B | |
| SCHEMBL1591923 | 0.91 | — | — | |
| Vinyl Chloride SCHEMBL11122339 | 0.91 | TET3 (0.43) | TET3KMT2AFBXL19CXXC5KDM2B | |
| SCHEMBL149678 | 0.91 | — | — | |
| SCHEMBL505654 | 0.91 | ALDH1A1 (0.48) | TET3KMT2AFBXL19CXXC5KDM2B | |
| SCHEMBL25231611 | 0.89 | ALDH1A1 (0.55) | TET3KMT2AFBXL19CXXC5KDM2B | |
| SCHEMBL2558338 | 0.89 | ALDH1A1 (0.55) | TET3KMT2AFBXL19CXXC5KDM2B | |
| SCHEMBL329111 | 0.89 | ALDH1A1 (0.55) | TET3KMT2AFBXL19CXXC5KDM2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1763 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534663-B2 | Re-crosslinkable hyper-branched polymer gels based on a transamidation reaction | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2026-01-27 | — | — | US | claimed |
| US-12521089-B2 | Systems and methods for on-person wearable electronic devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-01-13 | — | — | US | claimed |
| EP-4619471-A1 | HIGH REFRACTIVE INDEX NANOIMPRINTABLE RESIN FOR OPTICAL WAVEGUIDE APPLICATIONS | Microsoft Technology Licensing, LLC (US) | 2025-09-24 | — | — | EP | claimed |
| EP-4090949-B1 | A HOLOGRAPHIC SENSOR | CAMBRIDGE ENTPR LTD (GB) | 2025-06-25 | — | — | EP | claimed |
| CN-120167001-A | High refractive index nanoimprintable resins for optical waveguide applications | 微软技术许可有限责任公司 | 2025-06-17 | — | — | CN | claimed |
| US-20250140903-A1 | ELECTROLYTE AND BATTERY COMPRISING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2025-05-01 | — | — | US | claimed |
| US-20250122414-A1 | THERMALLY STABLE ADDITIVE FOR WELLBORE TREATMENTS | HALLIBURTON ENERGY SERVICES, INC. | 2025-04-17 | — | — | US | claimed |
| US-20250122417-A1 | THERMALLY STABLE ADDITIVE FOR WELLBORE TREATMENTS | HALLIBURTON ENERGY SERVICES , INC. | 2025-04-17 | — | — | US | claimed |
| WO-2025080385-A1 | THERMALLY STABLE ADDITIVE FOR WELLBORE TREATMENTS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-04-17 | — | — | WO | claimed |
| WO-2025080281-A1 | THERMALLY STABLE ADDITIVE FOR WELLBORE TREATMENTS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-04-17 | — | — | WO | claimed |
| WO-1993021256-A1 | POLYETHERAMIDOAMINE SUPERABSORBENT HYDROGELS | SOCIETA' CONSORTILE RICERCHE ANGELINI S.P.A. (IT) | 1993-10-28 | — | — | WO | claimed |
| WO-1992012187-A1 | CHIRAL POLYMERS, THEIR PREPARATION AND USE IN PREPARING OPTICALLY ACTIVE PROPIONIC 2-ARYL ACIDS | RHONE-POULENC RORER S.A. (FR) | 1992-07-23 | — | — | WO | claimed |
| US-5077058-A | One step process for preparing cross-linked poly-β-alanine microspheres from acrylamide and a copolymerisable polyfunctional compound | L'OREAL (FR) | 1991-12-31 | — | — | US | claimed |
| EP-0403395-A1 | Process for the one-step preparation of cross-linked poly beta-alanine from acrylamide and a polyfunctional compound copolymerisable therewith | L'OREAL (FR) | 1990-12-19 | — | — | EP | claimed |
| EP-0349402-A2 | Solid-phase process for the preparation of polypeptides | RHONE-POULENC NUTRITION ANIMALE (FR) | 1990-01-03 | — | — | EP | claimed |
| US-4874490-A | Pre-cast gel systems for two-dimensional electrophoresis | BIO-RAD LABORATORIES, INC. (US) | 1989-10-17 | — | — | US | claimed |
| US-4338401-A | Immobilization of enzymes | ITALFARMACO S.P.A. (IT) | 1982-07-06 | — | — | US | claimed |
| US-4228152-A | BOUND TO A POLYACRYLIC OR POLYMETHACRYLIC BACKBONE THROUGH ESTER OR AMIDIC BONDS | FERRUTI PAOLO | 1980-10-14 | — | — | US | claimed |
| US-4223011-A | OXYALKYLENE, AMINOALKYLENE; POLYACRYLIC ACID | FERRUTI PAOLO | 1980-09-16 | — | — | US | claimed |
| US-4145320-A | BOUND TO POLY-ACRYLIC OR METHACRYLIC UNITS THROUGH OXYALKYLENIC, AMINOALKYLENIC, OR OXYAMINOALKYLENIC CHAINS | FERRUTI PAOLO | 1979-03-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534663-B2 | Re-crosslinkable hyper-branched polymer gels based on a transamidation reaction | PHOSPHO1, TERT, AS3MT | TET3 499/4885KMT2A 2872/4885FBXL19 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.